Displaying 1 - 50 of 187396 results
Released Company Title Industry Topic
22 Feb 2023
23:22 CET
SALMONES CAMANCHAC Salmones Camanchaca – Q4 2022 results 45102010 Farming, Fishing, Ranching and Plantations Annual financial and audit Reports
22 Feb 2023
22:30 CET
MDXHEALTH MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023 20103010 Biotechnology Commercial results
22 Feb 2023
22:30 CET
ZAPTEC ASA Zaptec ASA: Purchase of shares by CEO and CFO 50202040 Electronic Equipment: Other Mandatory notification of trade primary insiders
22 Feb 2023
22:29 CET
PERSHING SQUARE HOLDING Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value and Year-To-Date Return As Of 21 February 2023 30204000 Closed End Investments Other subject
22 Feb 2023
21:45 CET
Sandnes Sparebank Valgmøte for egenkapitalbeviseiere er avholdt 30101010 Banks Annen informasjonspliktig regulatorisk informasjon
22 Feb 2023
21:30 CET
NORDEA BANK Nordea Bank Abp: Repurchase of own shares on 22.02.2023 30101010 Banks Acquisition or disposal of the issuer’s own shares
22 Feb 2023
20:13 CET
METROPOLE TV L’ARCOM SÉLECTIONNE M6 POUR LA POURSUITE DE SA DIFFUSION EN TNT 40301035 Radio and TV Broadcasters Other subject
22 Feb 2023
20:13 CET
METROPOLE TV ARCOM Selects M6 to Continue Its Broadcast on TNT 40301035 Radio and TV Broadcasters Other subject
22 Feb 2023
19:56 CET
KYOTO GROUP AS Kyoto Group AS: New share capital registered 60102020 Renewable Energy Equipment Additional regulated information required to be disclosed under the laws of a Member State
22 Feb 2023
19:20 CET
Pareto Bank ASA Transaksjoner foretatt under tilbakekjøpsprogram for Pareto Bank ASA 30101010 Banks Utsteders meldeplikt ved handel i egne aksjer
22 Feb 2023
19:20 CET
Pareto Bank ASA Transactions made under the buy-back program for Pareto Bank ASA 30101010 Banks Acquisition or disposal of the issuer’s own shares
22 Feb 2023
19:15 CET
OTOVO ASA Otovo ASA - Notification of primary insider trade and disclosure of large shareholdings 40401030 Specialty Retailers Mandatory notification of trade primary insiders
22 Feb 2023
19:00 CET
AMG ADVANCED METALLURGICAL GROUP AMG’s Low-Cost Lithium Operations Drive AMG to Record-Setting Full Year Earnings 50204000 Machinery: Industrial Commercial results
22 Feb 2023
18:44 CET
ARRIBATEC GROUP ASA Arribatec Group ASA: Extraordinary general meeting held 40202015 Household Furnishings Additional regulated information required to be disclosed under the laws of a Member State
22 Feb 2023
18:30 CET
ERAMET Eramet: Record year with EBITDA above €1.5bn and very strong deleveraging 55102050 Nonferrous Metals Income
22 Feb 2023
18:30 CET
UMICORE Umicore - Transparantieverklaring van BlackRock, Inc. 55201020 Specialty Chemicals Other subject
22 Feb 2023
18:30 CET
UMICORE Umicore - Transparency notification by BlackRock, Inc. 55201020 Specialty Chemicals Other subject
22 Feb 2023
18:30 CET
ERAMET Eramet : Année record avec un EBITDA supérieur à 1,5 Md€ et un très fort désendettement 55102050 Nonferrous Metals Income
22 Feb 2023
18:30 CET
MEMSCAP REGPT MEMSCAP : WEBINAIRE ACTIONNAIRES INDIVIDUELS MERCREDI 8 MARS 2023 10102010 Semiconductors Meetings / events
22 Feb 2023
18:30 CET
UMICORE Umicore - Déclaration de transparence par BlackRock, Inc. 55201020 Specialty Chemicals Other subject
22 Feb 2023
18:26 CET
SHELL PLC Transaction in Own Shares 60101000 Integrated Oil and Gas Other subject
22 Feb 2023
18:13 CET
KLEPIERRE INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SA AS OF JANUARY 31, 2023 35102045 Retail REITs Other subject
22 Feb 2023
18:13 CET
KLEPIERRE INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE KLÉPIERRE SA AU 31 JANVIER 2023 35102045 Retail REITs Other subject
22 Feb 2023
18:05 CET
ABIVAX Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors 20103010 Biotechnology Change in Capital
22 Feb 2023
18:05 CET
ABIVAX Abivax annonce le succès d’un financement cross-over sursouscrit de 130 millions d’euros au prix du marché, par des investisseurs américains et européens de premier plan 20103010 Biotechnology Other subject
22 Feb 2023
18:03 CET
ESSILORLUXOTTICA EssilorLuxottica renews license agreement for Target Optical 20102015 Medical Supplies Other subject
22 Feb 2023
18:03 CET
ESSILORLUXOTTICA EssilorLuxottica renouvelle son accord de licence sur Target Optical 20102015 Medical Supplies Other subject
22 Feb 2023
18:03 CET
ESSILORLUXOTTICA EssilorLuxottica rinnova l'accordo di licenza per Target Optical 20102015 Medical Supplies Other subject
22 Feb 2023
18:00 CET
TIETOEVRY Repurchase of own shares 10101010 Computer Services Acquisition or disposal of the issuer’s own shares
22 Feb 2023
18:00 CET
SWEDBANK AB Welcome to Swedbank's Annual General Meeting on 30 March 2023 30101010 Banks Additional regulated information required to be disclosed under the laws of a Member State
22 Feb 2023
18:00 CET
AELIS FARMA CORRIGE ET REMPLACE : Aelis Farma : Apport complémentaire au contrat de liquidité conclu avec Invest Securities 20103010 Biotechnology Other subject
22 Feb 2023
18:00 CET
L'OREAL L'Oréal: News release: Financial calendar update 40204035 Cosmetics Dividend
22 Feb 2023
18:00 CET
ALAN ALLMAN ASSOCIATES Alan Allman Associates confirme une croissance du chiffre d'affaires au-delà des attentes pour le quatrième trimestre 2022 et fixe ses objectifs de chiffre d'affaires pour 2023 30202000 Diversified Financial Services Sales, Income
22 Feb 2023
18:00 CET
NFL BIOSCIENCES S.A. NFL BIOSCIENCES: Inclusion of the first volunteer in the PRECESTO study 20103010 Biotechnology -
22 Feb 2023
18:00 CET
QUANTUM GENOMICS Quantum Genomics annonce un remaniement de son Conseil d'Administration et une restructuration de ses effectifs pour se focaliser sur de nouveaux projets 20103010 Biotechnology Legal
22 Feb 2023
18:00 CET
OSE IMMUNOTHERAPEUTICS OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology 20103010 Biotechnology Other subject
22 Feb 2023
18:00 CET
L'OREAL L'Oréal : Communiqué : "Mise à jour du calendrier financier" 40204035 Cosmetics Dividend
22 Feb 2023
18:00 CET
U10 CORP U10 - Chiffre d'affaires annuel 2022 : 183 m EUR 40202015 Household Furnishings Sales, Income
22 Feb 2023
18:00 CET
NFL BIOSCIENCES S.A. NFL BIOSCIENCES : 1ère inclusion de volontaire dans l’étude PRECESTO 20103010 Biotechnology -
22 Feb 2023
18:00 CET
QUANTUM GENOMICS Quantum Genomics announces reorganization of its Board of Directors and staff restructuration in order to focus on new projects 20103010 Biotechnology Legal
22 Feb 2023
18:00 CET
OSE IMMUNOTHERAPEUTICS OSE Immunotherapeutics fait un point d’étape sur OSE-127/S95011, un antagoniste du récepteur à l’IL-7, une approche innovante dans les maladies auto-immunes inflammatoires chroniques et en hématologie 20103010 Biotechnology Other subject
22 Feb 2023
17:55 CET
DRONE VOLT DRONE VOLT annonce la plus importante commande de son histoire 50201010 Aerospace Legal
22 Feb 2023
17:51 CET
LOTUS BAKERIES Disposal of treasury shares 45102020 Food Products Other subject
22 Feb 2023
17:45 CET
CERINNOV GROUP Cerinnov Group: Forte croissance de +43% de l’activité en 2022 à 14,6 M€ 50204000 Machinery: Industrial Sales
22 Feb 2023
17:45 CET
BILENDI BILENDI: 2022 : record revenues of €61.5 million (+39.5%) 40301020 Media Agencies Sales
22 Feb 2023
17:45 CET
BILENDI BILENDI: 2022 : chiffre d’affaires record de 61,5 M€ (+39,5%) 40301020 Media Agencies Sales
22 Feb 2023
17:45 CET
NEXITY Nexity Renouvelle sa Ligne de Crédit Corporate pour un Montant de 800 Millions d’euros, Assortie de Critères Environnementaux 35101010 Real Estate Holding and Development Corporate life
22 Feb 2023
17:45 CET
NEXITY Nexity: 2022 full-year results 35101010 Real Estate Holding and Development Income
22 Feb 2023
17:45 CET
AIR LIQUIDE Air Liquide : Assemblée Générale Mixte du 3 mai 2023 : publication de l’avis de réunion 55201020 Specialty Chemicals Other subject
22 Feb 2023
17:45 CET
AXWAY SOFTWARE Axway Software : Excellents résultats annuels 2022 soutenus par un 4ème trimestre record 10101015 Software Other subject